KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) EBITDA (2016 - 2025)

Imax (IMAX) has disclosed EBITDA for 16 consecutive years, with $24.1 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 153.41% to $24.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.2 million through Dec 2025, up 92.03% year-over-year, with the annual reading at $84.2 million for FY2025, 92.03% up from the prior year.
  • EBITDA hit $24.1 million in Q4 2025 for Imax, down from $29.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $29.0 million in Q3 2025 to a low of -$10.8 million in Q1 2021.
  • Historically, EBITDA has averaged $8.9 million across 5 years, with a median of $10.5 million in 2023.
  • Biggest five-year swings in EBITDA: plummeted 396.83% in 2022 and later soared 14185.15% in 2023.
  • Year by year, EBITDA stood at $25.6 million in 2021, then crashed by 102.45% to -$629000.0 in 2022, then surged by 535.45% to $2.7 million in 2023, then soared by 247.28% to $9.5 million in 2024, then soared by 153.41% to $24.1 million in 2025.
  • Business Quant data shows EBITDA for IMAX at $24.1 million in Q4 2025, $29.0 million in Q3 2025, and $14.3 million in Q2 2025.